Tag: global regulatory timelines

Time Management and Submission Timelines for Responses

Posted on digi By digi

Time Management and Submission Timelines for Responses Mastering Regulatory Response Timelines and Time Management Strategies Understanding Regulatory Clocks and Review Cycles When health authorities such as the FDA, EMA, MHRA, PMDA, or Health Canada issue questions during the review of a submission (IND, NDA, BLA, ANDA, CTA, MAA), they often trigger specific timelines for the…

Read More “Time Management and Submission Timelines for Responses” »

Regulatory Query Response Handling, Regulatory Submissions and Approvals

Clinical Trial Notification (CTN) vs CTA: A Global View

Posted on digi By digi

Clinical Trial Notification (CTN) vs CTA: A Global View Clinical Trial Notification vs Clinical Trial Application: A Global Regulatory Perspective Introduction: Diverging Regulatory Pathways Across the Globe Conducting clinical trials across international markets requires sponsors to understand and navigate a complex patchwork of regulatory systems. Two primary models are widely used for initiating trials: the…

Read More “Clinical Trial Notification (CTN) vs CTA: A Global View” »

CTA (Clinical Trial Application), Regulatory Submissions and Approvals

Timing Requirements for Trial Registration and Updates

Posted on digi By digi

Timing Requirements for Trial Registration and Updates Understanding Deadlines for Clinical Trial Registration and Timely Updates Why Timing Matters in Trial Disclosure Timely registration and updates of clinical trials are central to transparency, ethical conduct, and regulatory compliance. Delays in public disclosure can mislead stakeholders, mask adverse outcomes, and hinder scientific progress. To prevent these…

Read More “Timing Requirements for Trial Registration and Updates” »

Clinical Trial Transparency and Ethics, Trial Disclosure Obligations

Start-Up Timelines Across Global Regions in Clinical Trials

Posted on digi By digi

Understanding Regional Differences in Clinical Study Start-Up Timelines Launching a clinical trial globally requires careful planning around regional variations in start-up timelines. Different countries and regulatory agencies follow unique pathways for ethics approvals, regulatory submissions, and site activation. This article provides a practical, comparative guide on start-up timelines across major global regions to help trial…

Read More “Start-Up Timelines Across Global Regions in Clinical Trials” »

Clinical Research Operations, Study Start-Up Activities